About
Jim Van heusden is partner venture capital at Gimv and focuses on investments in Life Sciences. He currently serves on the board of Ablynx (Belgium), ActoGeniX (Belgium) , Nereus Pharmaceuticals (USA), and Pronota (Belgium) and has been a board member at CropDesign (acquired by BASF). Prior to joining Gimv in 2001, he worked as a senior scientist at Janssen Pharmaceutica, a Johnson & Johnson company, where he also served on the research management committee of the collaboration with Rigel Pharmaceuticals (US). Jim Van heusden holds BSc and MSc degrees in chemistry and biochemistry from the University of Antwerp (Belgium) and a Ph.D in molecular and cellular biology from the University of Maastricht (The Netherlands).
Position in the VCSift Database
- • 2 investors at Prosensa are tracked.
- • 1 investors hold the Supervisory Board member role in VCSift. Jim Van heusden is one of them.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Waasmunster, Belgium
Contact Information
Find more investors like Jim
Search Investors